| 29.04 07:00 | *DJ Addex Provides Update on ADX71149 Phase 2 Epilepsy Study |
| 29.04 07:00 | Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study |
| 19.04 07:00 | *DJ Addex to Present at the Swiss Biotech Day 2024 |
| 19.04 07:00 | Press Release: Addex to Present at the Swiss Biotech Day 2024 |
| 18.04 07:00 | *DJ Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update |
| 18.04 07:00 | Press Release: Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update |
| 11.04 07:00 | Press Release: Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 |
| 03.04 07:00 | *DJ Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders |
| 03.04 07:00 | Press Release: Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders |
| 03.04 07:00 | Press Release: Addex and Perceptive Launch -2- |
| 14.03 07:00 | *DJ Addex to Present at the Bio-Europe Spring 2024 Conference |
| 14.03 07:00 | Press Release: Addex to Present at the Bio-Europe Spring 2024 Conference |
| 31.01 07:00 | *DJ Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. |
| 31.01 07:00 | Press Release: Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. |
| 09.01 07:00 | *DJ Addex to Present at the Swiss Equities Baader Conference |
| 09.01 07:00 | Press Release: Addex to Present at the Swiss Equities Baader Conference |
| 05.01 07:30 | *DJ Addex to Present at Biotech Showcase(TM) 2024 |
| 05.01 07:30 | Press Release: Addex to Present at Biotech Showcase(TM) 2024 |
| 20.12 07:00 | *DJ Addex Shareholders Approve All Resolutions at Extraordinary General Meeting |
| 20.12 07:00 | Press Release: Addex Shareholders Approve All Resolutions at Extraordinary General Meeting |
|
|
